RDNT — RadNet Inc. stock price and chart

Share this page

RDNT

$68.80-2.29%

as of close, Oct 16, 2026

☾ AH $68.80 -2.29%

RadNet Inc.Stock · HealthcareRussell 2000 0.1%Nasdaq Composite 0.01%US Stock Market 0.006%Russell 3000 0.006%

PeersMRNALLYMDTUNHJNJTMO

Technical analysis2

Overlay lines0

Addendum charts0

VolumeEEEE

20162019202120242026

10.020.030.040.050.060.070.080.0010.0M$68.80

2026-10-16

Price$68.80

MA20$65.03

MA50$68.69

Vol2.7M

What would $1,000 invested in RDNT be worth today? →

RDNT returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $68.80
YTD price return: -3.57%
YTD total return: -3.57%
Next earnings: Nov 9, 2026
Market cap: 5.4B2016-12 299.7M2026-10 5.4B+1707.0% over the window
Enterprise value: 7.1B
Shares outstanding: 78.7M2016-06 46.4M2026-06 78.7M+69.5% over the window
52W low: $50.82
52W high: $85.84
From 52W high: -19.85%
From 52W low: +35.38%
52W range: 51%

Volume

Rel volume: 0.57×
30D volume: 673.1K
30D $ vol: 48.9M

Fundamentals

Sales (ttm): 2.3B2016-06 859M2026-06 2.3B+164.1% over the window
Sales/share: $28.832016-06 $18.502026-06 $28.83+55.8% over the window
EPS (ttm): -$0.272016-06 $0.242026-06 -$0.27-213.6% over the window
FCF (ttm): 72.4M2016-12 32.4M2026-06 72.4M+123.4% over the window
FCF/share: $0.922016-12 $0.692026-06 $0.92+34.0% over the window
Book value/share: $13.932016-06 $0.712026-06 $13.93+1848.4% over the window
Net margin: -0.93%2016-06 1.3%2026-06 -0.9%-174.2% over the window
ROE: -1.93%2016-06 32.4%2026-06 -1.9%-105.9% over the window
ROA: -0.50%2016-06 1.3%2026-06 -0.5%-138.4% over the window
Debt / equity: 1.19×2016-12 11.762026-06 1.19-89.9% over the window
Current ratio: 1.482016-06 1.482026-06 1.48+0.1% over the window

Growth (CAGR, ttm) · 10Y

Sales: +18.94%2025-06-30 → 2026-06-301.9B → 2.3B (+18.9% total)+14.08%2023-06-30 → 2026-06-301.5B → 2.3B (+48.5% total)+12.68%2021-06-30 → 2026-06-301.2B → 2.3B (+81.7% total)+10.20%2016-06-30 → 2026-06-30859M → 2.3B (+164.1% total)
FCF: -4.79%2025-06-30 → 2026-06-3076M → 72.4M (-4.8% total)+22.68%2023-06-30 → 2026-06-3039.2M → 72.4M (+84.7% total)-1.29%2021-06-30 → 2026-06-3077.2M → 72.4M (-6.3% total)+11.06%2015-12-31 → 2026-06-3024.1M → 72.4M (+200.6% total)
Shares: +2.32%2025-06-30 → 2026-06-3076.9M → 78.7M (+2.3% total)+5.11%2023-06-30 → 2026-06-3067.8M → 78.7M (+16.1% total)+8.17%2021-06-30 → 2026-06-3053.1M → 78.7M (+48.1% total)+5.42%2016-06-30 → 2026-06-3046.4M → 78.7M (+69.5% total)

Per-share growth (CAGR, ttm) · 10Y

Sales/share: +16.25%2025-06-30 → 2026-06-30$24.80 → $28.83 (+16.2% total)+8.54%2023-06-30 → 2026-06-30$22.55 → $28.83 (+27.9% total)+4.17%2021-06-30 → 2026-06-30$23.50 → $28.83 (+22.7% total)+4.54%2016-06-30 → 2026-06-30$18.50 → $28.83 (+55.8% total)
FCF/share: -6.95%2025-06-30 → 2026-06-30$0.99 → $0.92 (-6.9% total)+16.72%2023-06-30 → 2026-06-30$0.58 → $0.92 (+59.0% total)-8.75%2021-06-30 → 2026-06-30$1.45 → $0.92 (-36.7% total)+5.78%2015-12-31 → 2026-06-30$0.51 → $0.92 (+80.3% total)
Book value/share: +14.92%2025-06-30 → 2026-06-30$12.12 → $13.93 (+14.9% total)+16.75%2023-06-30 → 2026-06-30$8.75 → $13.93 (+59.1% total)+30.30%2021-06-30 → 2026-06-30$3.71 → $13.93 (+275.6% total)+34.58%2016-06-30 → 2026-06-30$0.71 → $13.93 (+1848.4% total)
Price: -11.11%2025-10-16 → 2026-10-16$77.39 → $68.80 (-11.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+32.77%2023-10-16 → 2026-10-16$29.39 → $68.80 (+134.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+19.03%2021-10-15 → 2026-10-16$28.78 → $68.80 (+139.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+24.82%2016-10-14 → 2026-10-16$7.49 → $68.80 (+818.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: -11.11%2025-10-16 → 2026-10-16$77.39 → $68.80 (-11.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+32.77%2023-10-16 → 2026-10-16$29.39 → $68.80 (+134.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+19.03%2021-10-15 → 2026-10-16$28.78 → $68.80 (+139.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+24.82%2016-10-14 → 2026-10-16$7.49 → $68.80 (+818.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: -252.4×2016-12 67.662026-10 -256.49-479.1% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 76.5×2016-12 8.832026-10 76.52+767.1% over the window
Fwd P/E: 79.3×
P/S (ttm)Market cap ÷ TTM revenue.: 2.4×2016-12 0.342026-10 2.39+597.1% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 4.9×2016-12 8.172026-10 4.94-39.5% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 74.8×2016-12 12.452026-10 74.83+501.1% over the window
EV/EBITDA (fy): 29.3×
EV/Sales (ttm): 3.1×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 1.34%2016-12 10.8%2026-06 1.5%-86.2% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 78.7M ÷ 76.9M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -2.32%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-2.32%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($4.4B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: -2.32%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($5.4B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 0.00%2016-09 0.0%2026-06 0.0%
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $0) ÷ today's market cap ($5.4B). Same caveat as the cash buyback yield.: 0.00%2016-09 0.0%2026-06 0.0%

Vs own 10Y history

P/E: 93rd
P/OI: 92nd
P/S: 84th
P/B: 33rd
P/FCF: 85th

Bar = where today’s multiple sits in RDNT’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-16#

-2.29%

-2.98%

-9.21%

+9.22%

YTD

-3.57%

-11.10%

+139.05%

Financial statements

Open full RDNT financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+10.48%	+0.43%
JNJ	Johnson & Johnson	-4.38%	+0.90%
ABBV	AbbVie Inc.	+8.73%	+0.71%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+6.97%	-1.29%
MRK	Merck & Co. Inc.	+0.72%	+0.52%
NVS	Novartis AG	+8.59%	+0.16%
TMO	Thermo Fisher Scientific Inc.	+6.41%	-0.93%
AMGN	Amgen Inc.	+14.92%	-0.35%

RDNT — RadNet Inc. price, chart and key statistics